MSP involves the treatment of DNA with sodium bisulfite, which converts unmethylated cytosines to uracil, while methylated cytosines remain unchanged. This modified DNA is then amplified using PCR with primers specific for either methylated or unmethylated sequences. The presence or absence of PCR products indicates the methylation status of the target DNA.
